发明名称 IL-17 binding proteins
摘要 Proteins that bind IL-17 and/or IL-17F are described along with there use in composition and methods for treating, preventing, and diagnosing IL-17 related diseases and for detecting IL-17 in cells, tissues, samples, and compositions.
申请公布号 US8779101(B2) 申请公布日期 2014.07.15
申请号 US201313959648 申请日期 2013.08.05
申请人 AbbVie, Inc. 发明人 Hsieh Chung-Ming;Hugunin Margaret;Murtaza Anwar;McRae Bradford L.;Kutskova Yuliya;Memmott John E.;Perez Jennifer M.;Zhong Suju;Tarcsa Edit;Clabbers Anca;Wallace Craig;Bryant Shaughn H.;Leddy Mary R.
分类号 A61K39/00 主分类号 A61K39/00
代理机构 Lathrop & Gage, LLP 代理人 Steel Diana M.;Velema, Esq. James H.;Lathrop & Gage, LLP
主权项 1. A binding protein comprising first and second polypeptide chains, wherein said first polypeptide chain comprises a first VD1-(X1)n-VD2-C-(X2)n, wherein VD1 is a first heavy chain variable domain; VD2 is a second heavy chain variable domain; C is a heavy chain constant domain; X1 is a linker with the proviso that it is not CH1; X2 is an Fc region; n is 0 or 1; and wherein said second polypeptide chain comprises a second VD1-(X1)n-VD2-C-(X2)n, wherein VD1 is a first light chain variable domain; VD2 is a second light chain variable domain; C is a light chain constant domain; X1 is a linker with the proviso that it is not CH1; X2 does not comprise an Fc region; n is 0 or 1; and wherein the binding protein is capable of binding human IL-17 and TNF-α; wherein, in the first polypeptide chain, said VD1 or VD2 heavy chain variable domain comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 565, 670, 720, 740, 845, and 875; and wherein, in the second polypeptide chain, said VD1 or VD2 light chain variable domain comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 570, 675, 725, 745, 850, and 880.
地址 North Chicago IL US